Gland Pharma Limited (GLAND) — Free Cash Flow Generation Index
Gland Pharma Limited (GLAND) has a Free Cash Flow Generation Index of 0.67x as of September 2025. Free cash flow of Rs3.99 Billion represents 1% of operating cash flow (Rs5.93 Billion). Explore GLAND capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Gland Pharma Limited Free Cash Flow Generation Index (2017–2026)
Historical FCF Generation Index trend for Gland Pharma Limited across 10 annual periods. For the full cash flow conversion analysis, see Gland Pharma Limited operating cash flow efficiency.
Annual Free Cash Flow Generation for Gland Pharma Limited (2017–2026)
Year-by-year Free Cash Flow Generation Index for Gland Pharma Limited. Check GLAND capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (INR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.60x | Rs7.41 Billion | Rs12.31 Billion | Rs4.91 Billion | ▲ +3.8% |
| 2025 | 0.58x | Rs5.30 Billion | Rs9.15 Billion | Rs3.85 Billion | ▼ -4.8% |
| 2024 | 0.61x | Rs6.07 Billion | Rs9.97 Billion | Rs3.90 Billion | ▲ +57.3% |
| 2023 | 0.39x | Rs1.41 Billion | Rs3.64 Billion | Rs2.23 Billion | ▲ +13.9% |
| 2022 | 0.34x | Rs2.69 Billion | Rs7.91 Billion | Rs5.22 Billion | ▼ -45.4% |
| 2021 | 0.62x | Rs3.76 Billion | Rs6.05 Billion | Rs2.29 Billion | ▼ -13.9% |
| 2020 | 0.72x | Rs5.06 Billion | Rs7.01 Billion | Rs1.95 Billion | ▲ +170.3% |
| 2019 | 0.27x | Rs495.11 Million | Rs1.85 Billion | Rs1.36 Billion | ▼ -53.8% |
| 2018 | 0.58x | Rs1.17 Billion | Rs2.02 Billion | Rs851.75 Million | ▼ -23.5% |
| 2017 | 0.76x | Rs3.60 Billion | Rs4.76 Billion | Rs1.16 Billion | — |